The market's pushed a bit higher Tuesday morning, as traders looked for bargain investments. Keep an eye on VCEL, they traded up 16% Tuesday morning! Keep an eye on TLGT, they just announced they have received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for Lidocaine Ointment USP 5%. Symbol: VCEL Co Name: Vericel Corporation Website: www.vcel.com Breakout Catalyst: (+) Vericel Corporation (formerly Aastrom Biosciences, Inc.) is a leader in developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. TLGT recently announced that they have received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for Lidocaine Ointment USP 5%. This is Teligent's third approval from its internally developed pipeline of generic pharmaceutical products. Symbol: TLGT Co Name: Teligent Inc. Website: www.Teligent.com. Breakout Catalyst: (+) Teligent Inc. is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Best Regards, The PennyStockScholar Team DON'T MISS ANOTHER HOT OPPORTUNITY TO MAKE HUGE PROFITS! GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY You can read our full disclaimer here penny stock scholar disclaimer . html Please be advised that we have NOT been compensated to profile VCEL, TLGT for a one day investor awareness program. WE OWN NO SHARES. Penny Stock Scholar 4417 13th St., Saint Cloud, FL 34769, USA To unsubscribe or change subscriber options visit: http://www.aweber.com/z/r/?jKyMTIzszLSsTExsrAxMrLRGtMwMHBwcnAys
